STAT3 and gastric neoplasm: This supported the hypothesis that SIRT1 and STAT3 functioned independently in advanced tumors as important oncogenes to maintain the malignancy of stomach tumors resulting in poor survival outcomes in patients with high expression of both SIRT1 and STAT3.